PMID: 22778153

Sen R, Natarajan K, Bhullar J, Shukla S, Fang HB, Cai L, Chen ZS, Ambudkar SV, Baer MR
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.
Mol Cancer Ther. 2012 Sep;11(9):2033-44. doi: 10.1158/1535-7163.MCT-12-0302. Epub 2012 Jul 9., [PubMed]
Sentences
No. Mutations Sentence Comment
25 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 22778153:25:101
status: NEW
view ABCG2 p.Arg482Thr details
Doxorubicin- and verapamil-selected MCF7/AdrVp breast carcinoma cells, overexpressing ABCG2 with the R482T mutation (25), were obtained from Dr. Douglas Ross, University of Maryland Greenebaum Cancer Center, Baltimore, MD, and flavopiridol-selected MCF-7/Flv1000 cells (26), overexpressing wild-type ABCG2, from Dr. Susan Bates, National Cancer Institute. Login to comment
27 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 22778153:27:101
status: NEW
view ABCG2 p.Arg482Thr details
Doxorubicin- and verapamil-selected MCF7/AdrVp breast carcinoma cells, overexpressing ABCG2 with the R482T mutation (25), were obtained from Dr. Douglas Ross, University of Maryland Greenebaum Cancer Center, Baltimore, MD, and flavopiridol-selected MCF-7/Flv1000 cells (26), overexpressing wild-type ABCG2, from Dr. Susan Bates, National Cancer Institute. Login to comment
67 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 22778153:67:212
status: NEW
view ABCG2 p.Arg482Thr details
The effect in MCF7/AdrVp was less than in 8226/MR20 and K562/ABCG2, likely because of a greater degree of resistance in the solid tumor in relation to hematopoietic cell lines, rather than to the presence of the R482T mutation in MCF7/AdrVp, though the latter is also possible. Login to comment
68 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 22778153:68:12
status: NEW
view ABCG2 p.Arg482Thr details
Because the R482T ABCG2 mutation is not clinically relevant, we did not pursue this distinction. Login to comment
69 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 22778153:69:212
status: NEW
view ABCG2 p.Arg482Thr details
The effect in MCF7/AdrVp was less than in 8226/MR20 and K562/ABCG2, likely because of a greater degree of resistance in the solid tumor in relation to hematopoietic cell lines, rather than to the presence of the R482T mutation in MCF7/AdrVp, though the latter is also possible. Login to comment
70 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 22778153:70:12
status: NEW
view ABCG2 p.Arg482Thr details
Because the R482T ABCG2 mutation is not clinically relevant, we did not pursue this distinction. Login to comment